The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma

Part of paid clinical trials in Alexandria, Minnesota.

Sponsor
Vance Thompson Vision
Study ID
NCT07401290
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Pseudoexfoliation Glaucoma

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Direct selective laser trabeculoplasty — DEVICE
    A non-invasive laser procedure for treating glaucoma and ocular hypertension by improving the eye's natural fluid drainage

Study Details

Prospective, multi-center, single arm, interventional study evaluating DSLT in patients with pseudoexfoliative glaucoma.

Key Dates

Start date
Mar 31, 2026
Status verified
Feb 2026
Primary completion
Mar 31, 2028
Completion
Mar 31, 2028

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treated Group
    Patients treated with DSLT

Primary Outcome Measure

Primary Effective Endpoint [ Time Frame: 6 months ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Vance Thompson VisionAlexandriaMinnesota56308
Deborah Ristvedt, DO
[email protected]
(320) 762-2166
Miranda Danielson
[email protected]
(320) 762-2166
Vance Thompson VisionOmahaNebraska68137
Lorraine Provencher, MD
[email protected]
4025069970
Dana Dubas
4025069970
Vance Thompson VisionFargoNorth Dakota58078
Michael Greenwood, MD
[email protected]
(701) 566-5390
McKenzie Schueller
[email protected]
(701) 566-5390

Find similar trials in Alexandria, MN

By research site
Vance Thompson Vision· Alexandria, MNVance Thompson Vision· Omaha, NEVance Thompson Vision· Fargo, ND

Related Studies